Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosemary R Berardi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Journal of the American Pharmacists Association : Japha|February 18, 2004
Safety and tolerability of tegaserod in irritable bowel syndrome managementRosemary R Berardi
The Annals of Pharmacotherapy|December 22, 2005
Cyclosporine for severe ulcerative colitisCo Q D Pham, Carly B Efros, Rosemary R Berardi
P & T : a Peer-Reviewed Journal for Formulary Management|September 21, 2011
The value of branded proton pump inhibitors: formulary considerationsDavid A Peura, Rosemary R Berardi, Javier Gonzalez, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Journal of the American Pharmacists Association : Japha|February 18, 2004
Safety and tolerability of tegaserod in irritable bowel syndrome managementRosemary R Berardi
The Annals of Pharmacotherapy|December 22, 2005
Cyclosporine for severe ulcerative colitisCo Q D Pham, Carly B Efros, Rosemary R Berardi
P & T : a Peer-Reviewed Journal for Formulary Management|September 21, 2011
The value of branded proton pump inhibitors: formulary considerationsDavid A Peura, Rosemary R Berardi, Javier Gonzalez, et al.
Pageof 1